Radiopharm Theranostics Limited December 2024 Form 6-K Report: Key Announcements & Updates

Here are the key insights extracted from the provided section of the financial report:

1. Form Type: The document is a Form 6-K, which is typically used by foreign private issuers to report significant events or updates.
2. Registrant Information:

• Company Name: Radiopharm Theranostics Limited
• Commission File Number: 001-41621
• Address: Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia

3. Reporting Period: The report is for the month of December 2024.
4. Public Announcements: The company published four announcements to the Australian Securities Exchange on December 18, 2024:

• Announcement Titles:
• • "Application for quotation of securities – RAD"
  • "Notification regarding unquoted securities – RAD"
  • "Change of Director’s Interest Notices x7"
  • "Notification of cessation of securities – RAD"

5. Exhibits Included: The report includes copies of the public notices as exhibits. The exhibit numbers and descriptions are as follows:

• Exhibit 99.1: Application for quotation of securities – RAD
• Exhibit 99.2: Notification regarding unquoted securities – RAD
• Exhibit 99.3: Change of Director’s Interest Notices x7
• Exhibit 99.4: Notification of cessation of securities – RAD

6. Filing Status: The report clarifies that it is not deemed "filed" for the purposes of the Securities Exchange Act of 1934 and will not be incorporated by reference unless specified.
7. Signature: The report is signed by Phillip Hains, the Company Secretary, indicating authorization and compliance with filing requirements.

This summary captures the essential elements and updates from the report, which may be relevant for investors, analysts, and stakeholders in understanding the company's activities and regulatory compliance.